The combination of a nuclear HMGB1-positive and HMGB2-negative expression is potentially associated with a shortened survival in patients with pancreatic ductal adenocarcinoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The combination of a nuclear HMGB1-positive and HMGB2-negative expression is potentially associated with a shortened survival in patients with pancreatic ductal adenocarcinoma
Authors
Keywords
Pancreatic ductal adenocarcinoma (PDAC), HMGB1, HMGB2, Lymphatic permeation (LI), Prognosis
Journal
TUMOR BIOLOGY
Volume 35, Issue 10, Pages 10555-10569
Publisher
Springer Nature
Online
2014-07-25
DOI
10.1007/s13277-014-2328-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-200c inhibits metastasis of breast cancer cells by targeting HMGB1
- (2014) Bao-ping Chang et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Polypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomas
- (2013) S Kitada et al. BRITISH JOURNAL OF CANCER
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
- (2012) Y Kanda BONE MARROW TRANSPLANTATION
- Strong YB-1 expression is associated with liver metastasis progression and predicts shorter disease-free survival in advanced gastric cancer
- (2012) Ying Wu et al. JOURNAL OF SURGICAL ONCOLOGY
- Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival
- (2011) Z Li et al. BRITISH JOURNAL OF CANCER
- Effect of HMGB1 silencing on cell proliferation, invasion and apoptosis of MGC-803 gastric cancer cells
- (2011) Bao Song et al. CELL BIOCHEMISTRY AND FUNCTION
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting Epigenetic Regulation of miR-34a for Treatment of Pancreatic Cancer by Inhibition of Pancreatic Cancer Stem Cells
- (2011) Dara Nalls et al. PLoS One
- Role of ZNF143 in tumor growth through transcriptional regulation of DNA replication and cell-cycle-associated genes
- (2010) Hiroto Izumi et al. CANCER SCIENCE
- Advanced pancreatic carcinoma: current treatment and future challenges
- (2010) Anastasios Stathis et al. Nature Reviews Clinical Oncology
- Epigenetics in cancer
- (2009) S. Sharma et al. CARCINOGENESIS
- Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma
- (2009) Xingjun Yao et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The expression of HMGB1 protein and its receptor RAGE in human malignant tumors
- (2009) Nora Kostova et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage
- (2009) N. F. Krynetskaia et al. MOLECULAR CANCER THERAPEUTICS
- Tumor-Node-Metastasis Staging of Pancreatic Adenocarcinoma
- (2008) M. H. G. Katz et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Overexpression of High Mobility Group (HMG) B1 and B2 Proteins Directly Correlates with the Progression of Squamous Cell Carcinoma in Skin
- (2008) Ashok Sharma et al. CANCER INVESTIGATION
- Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
- (2008) A. C. Mita et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started